Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: an updated systematic …
W Li, J Seo, DG Kokkinidis… - … Journal of Stroke, 2023 - journals.sagepub.com
Introduction: Heart failure (HF) is a major public health issue associated with significantly
increased risk of stroke. It remains uncertain whether oral anticoagulation (OAC) in patients …
increased risk of stroke. It remains uncertain whether oral anticoagulation (OAC) in patients …
Direct oral anticoagulants (DOAC) versus warfarin for the treatment of left ventricular thrombus (LVT) in patients with or without cardiorenal comorbidities, including …
N Nso, K Emmanuel, H Ayinde, A Iluyomade - Circulation, 2021 - Am Heart Assoc
Background: The medical management of left ventricular thrombus (LVT) is very challenging
due to the risk of embolic events. The current body of evidence supports the use of DOACs …
due to the risk of embolic events. The current body of evidence supports the use of DOACs …
Efficacy and safety of direct oral anticoagulants in patients with diabetes and nonvalvular atrial fibrillation: meta‐analysis of observational studies
B Cao, X Yao, L Zhang, X Hu, M Chen… - Cardiovascular …, 2021 - Wiley Online Library
Background. This meta‐analysis was performed to compare the efficacy and safety of direct
oral anticoagulants (DOACs) with vitamin K antagonists (VKAs) for stroke prevention in real …
oral anticoagulants (DOACs) with vitamin K antagonists (VKAs) for stroke prevention in real …
Use of direct oral anticoagulants in patients with atrial fibrillation and valvular heart lesions
L Di Biase - Journal of the American Heart Association, 2016 - Am Heart Assoc
Atrial fibrillation (AF) is the most common cardiac arrhythmia. It was estimated to affect up to
6.1 million Americans in 2010, and since AF is more common with increasing age, it is …
6.1 million Americans in 2010, and since AF is more common with increasing age, it is …
Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: a systematic review and meta …
N Patel, A Elzanaty, M Patel, E Elsheikh - Journal of the American College …, 2021 - jacc.org
Background Patients with atrial fibrillation (AF) and bioprosthetic valves (BPV) require long-
term anticoagulation and current recommendations support the use of vitamin K antagonists …
term anticoagulation and current recommendations support the use of vitamin K antagonists …
[HTML][HTML] Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus, V Wang… - PloS one, 2018 - journals.plos.org
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
[HTML][HTML] Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review …
Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic …
R Noviyani, S Youngkong, S Nathisuwan… - BMJ Evidence-Based …, 2022 - ebm.bmj.com
Objectives To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared
with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling …
with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling …
Use of direct oral anticoagulants in patients with left ventricular thrombus
K Chen, S Yu, W Zhu, X Liu - European Journal of Internal Medicine, 2024 - ejinme.com
Left ventricular thrombus (LVT), one of the most feared and common complications of acute
myocardial infarction (AMI), still causes morbidity and mortality in a proportion of patients …
myocardial infarction (AMI), still causes morbidity and mortality in a proportion of patients …
Direct anticoagulants and risk of myocardial infarction, a multiple treatment network meta-analysis
We assessed the cardiovascular safety of long-term direct-acting oral anticoagulant (DOAC)
treatment. A search of the medical literature was performed from inception until May 31 …
treatment. A search of the medical literature was performed from inception until May 31 …